Search - tctmd.com

Displaying 781 - 800 of 1078

Sort: Relevancy | Date

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Daily News

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Michael O'Riordan

March 14, 2016

News Daily News

Study Fails to Support Routine PCI for Older Patients With Syncope and CAD

March 07, 2016

News Daily News

Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality

February 28, 2016

News Daily News

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

Michael O'Riordan

February 28, 2016

News Daily News

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

February 25, 2016

News Conference News ISC 2016

REVASCAT: Thrombectomy’s Impact in Acute Stroke Extends to 1 Year

February 18, 2016

News Daily News

FDA: No Cardiovascular Event Reduction Claim for Ezetimibe

February 16, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

February 08, 2016

News Daily News

Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold

Michael O'Riordan

February 02, 2016

News Daily News

Leaving Significant Stenoses Untreated After PCI May Worsen 1-Year Outcomes: SCAAR Data

February 01, 2016

News Daily News

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Yael L. Maxwell

January 20, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

News Features

Possible Turf War Brewing Over Delivery of Acute Stroke Interventions

December 28, 2015

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

December 15, 2015

News Industry News

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

December 08, 2015

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Daily News

Post-PCI Neurological Events, Though Infrequent, Continue to Carry ‘Abysmal’ Consequences

November 22, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.